Oculopharyngeal Muscular Dystrophy Associated with Dementia

被引:9
|
作者
Mizoi, Yoshikazu [1 ]
Yamamoto, Toshimasa [1 ]
Minami, Narihiro
Ohkuma, Aya [1 ]
Nonaka, Ikuya
Nishino, Ichizo
Tamura, Naotoshi [1 ]
Amano, Takahiro [2 ]
Araki, Nobuo [1 ]
机构
[1] Saitama Med Univ, Dept Neurol, Fac Med, Saitama, Japan
[2] Keio Univ, Dept Med Educ Ctr, Fac Med, Tokyo 108, Japan
关键词
oculopharyngeal muscular dystrophy (OPMD); heterozygote; expanded PABPN1 (GCN) 17 mutation; dementia; ALZHEIMERS-DISEASE; CEREBROSPINAL-FLUID; LEWY BODIES;
D O I
10.2169/internalmedicine.50.5577
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We report genetically confirmed heterozygote oculopharyngeal muscular dystrophy (OPMD) accompanied by dementia, suggesting a possible causal association between OPMD and dementia. The proband first noticed bilateral ptosis, dysphagia, and proximal dominant muscle weakness in the lower extremities at age 53. Ten years later, she was found to have dementia with a score of 10/30 on the mini-mental state examination (MMSE). On PABPN1 gene analysis, the GCN repeat was expanded 17 times in one allele. In addition, the proband's younger brother exhibited myopathy and dementia. To our knowledge, this is the first report of genetically confirmed heterozygote OPMD associated with dementia.
引用
收藏
页码:2409 / 2412
页数:4
相关论文
共 50 条
  • [31] Oculopharyngeal muscular dystrophy or oculopharyngeal distal myopathy: case report
    Maeda, Marilia Yuri
    Hashimoto, Tais Yuri
    Oliveira Neto, Isabella Christina
    Neves, Luciano Rodrigues
    BRAZILIAN JOURNAL OF OTORHINOLARYNGOLOGY, 2017, 83 (02) : 235 - 238
  • [32] No evidence for heterogeneity in oculopharyngeal muscular dystrophy
    Kress, W
    Halliger-Keller, B
    Grimm, T
    Porschke, H
    Engelhardt, A
    Goebel, HH
    Müller-Mysok, B
    JOURNAL OF MEDICAL GENETICS, 1998, 35 (07) : 613 - 614
  • [33] Oculopharyngeal muscular dystrophy: postoperative complications
    Hélène G. Pellerin
    Pierre C. Nicole
    Claude A. Trépanier
    Martin R. Lessard
    Canadian Journal of Anesthesia, 2005, 52 (Suppl 1): : A192 - A192
  • [34] Gene therapy for oculopharyngeal muscular dystrophy
    Malerba, A.
    Klein, P.
    Bachtarzi, H.
    Jarmin, S.
    Cordova, G.
    Ferry, A.
    Strings, V.
    Espinoza, M. Polay
    Mamchaoui, K.
    Blumen, S.
    St Guily, J. Lacau
    Mouly, V.
    Graham, M.
    Butler-Browne, G.
    Suhy, D.
    Trollet, C.
    Dickson, G.
    NEUROMUSCULAR DISORDERS, 2017, 27 : S245 - S246
  • [35] Molecular investigation of oculopharyngeal muscular dystrophy
    Dion, Patrick
    Abu-Baker, Aida
    Messaed, Christiane
    Rouleau, Guy
    NEUROMUSCULAR DISORDERS, 2006, 16 : S113 - S113
  • [36] Oculopharyngeal muscular dystrophy: A polyalanine myopathy
    Bernard Brais
    Current Neurology and Neuroscience Reports, 2009, 9 : 76 - 82
  • [37] SURGERY IN OCULOPHARYNGEAL MUSCULAR-DYSTROPHY
    DURANCEAU, A
    FORAND, MD
    FAUTEUX, JP
    AMERICAN JOURNAL OF SURGERY, 1980, 139 (01): : 33 - 39
  • [38] Transcription dysregulation in oculopharyngeal muscular dystrophy
    Abu-Baker, A
    Laganiere, J
    Neri, C
    Rouleau, G
    NEUROMUSCULAR DISORDERS, 2005, 15 (9-10) : 707 - 708
  • [39] Oculopharyngeal muscular dystrophy - A case report
    Patt, S
    Brodhun, M
    Fitzek, C
    Terborg, C
    Kress, W
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2002, 199 : S110 - S110